Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary
Neurol 98:31-43, Price, R.,et al, 2022
Distal Symmetric Polyneuropathy in 2020
JAMA 324:90-92, Callaghan, B.C.,et al, 2020
Clinical Characteristics, Risk Factors, and Outcomes of POEMS Syndrome
Neurol 95:e268-e279, Keddie, S.,et al, 2020
Autoimmune CRMP5 Neuropathy Phenotype and Outcome Defined from 105 Cases
Neurol 90:e103-e110, Dubey, D.,et al, 2018
Pharmacotherapy for Diabetic Peripheral Neuropathy Pain and Quality of Life
Neurol 88:1958-1967, Waldfogel, J.M.,et al, 2017
Antiepileptic Drugs for Neuropathic Pain and Fibromyalgia
JAMA 312:182-183, Moore, A.,et al, 2014
Diagnosis and Management of Neuropathic Pain
BMJ 339:391-395, Freynhagen,R. &Bennett,M.I., 2009
Effectiveness, Tolerability, and Impact on Quality of Life of the 5% Lidocaine Patch in Diabetic Polyneuropathy
Arch Neurol 61:914-918, Barbano,R.L.,et al, 2004
Nonsystemic Vasculitic Neuropathy, Insights from a Clinical Cohort
Neurol 61:623-630, Collins,M.P.,et al, 2003
Painful Proximal Diabetic Neuropathy:Inflammatory Nerve Lesions and Spontaneous Favorable Outcome
Ann Neurol 41:762-770, Said,G.,et al, 1997
Neuropathic Pain of Peripheral Origin:Advances in Pharmacologic Treatment
Neurol 45 (suppl 8) :s17-s25995., Galer,B.S., 1995
Cytomegalovirus Multifocal Neuropathy in AIDS:Analysis of 15 Consecutive Cases
Neurol 44:2174-2182, Roullet,E.,et al, 1994
Neurologic Crises in Hereditary Tyrosinemia
NEJM 322:432-437, Mitchell,G.,et al, 1990
Peripheral Neuropathy as an Early Marker of AL Amyloidosis
Arch Int Med 149:358-360, Duston,M.A.,et al, 1989